Mountain View, CA (PRWEB) January 5, 2009
23andMe, Inc., the industry leader in personal genetics, announced today that it has hired two seasoned executives from the start-up and technology worlds to serve in top management positions at the company. Sarah Imbach, who most recently worked as LinkedIn's Vice-President of Revenue and Customer Operations, will be 23andMe's Chief Operating Officer, starting January 12, 2009. Larry Tesler, former VP of User Experience and Design at Yahoo!, recently joined 23andMe as Product Fellow.
Ms. Imbach is an experienced consumer Internet start-up executive and generalist in all areas of operations including finance, human resources, product, sales, customer service and risk. During her four and a half years at LinkedIn, she helped grow the company from 25 to 340 employees, from less than one million to more than thirty-two million users, and from zero revenue to profitability. Prior to that, she was an independent management consultant, working with several well-funded start-ups and also served as Senior Vice President, Customer Service Operations and Fraud at PayPal. Ms. Imbach will bring her considerable experience developing start-ups to bear at 23andMe, where she will manage the day-to-day operations of the business, including operations, finance and administration, product, engineering, and business development.
Mr. Tesler has over forty years of management and technical experience in the computer industry. He most recently worked at Yahoo! as Vice President of User Experience & Design and Research Fellow. Previously, he served as Vice President of Shopping Experience at Amazon.com, President of Stagecast, and Vice President and Chief Scientist of Apple. His early career included positions at the Xerox Palo Alto Research Center (PARC) and the Stanford University Department of Genetics. As Product Fellow at 23andMe, Mr. Tesler will advise and support the product and science teams, focusing on innovation, customer experience, and strategic planning.
Ms. Imbach said, "I have worked in the start-up world for most of my career and have always enjoyed helping new companies and entrepreneurs take their innovative visions to the next level. 23andMe is on the forefront of a new industry that has the potential to transform health care and the public's understanding of genetics, and I am excited to help the company realize this potential."
Mr. Tesler echoed this sentiment, "23andMe has a fantastic group of creative and dedicated people. The Personal Genome Service they have developed is intriguing, but it's just the beginning. We have new projects in the pipeline to enhance the user experience and further our goal of making genetics accessible to consumers."
"We are thrilled to have Sarah and Larry join our rapidly expanding team," said Linda Avey, 23andMe co-founder. "The past year has been one of consistent growth and development for 23andMe. It will be a great benefit to have Sarah and Larry help guide the company in the coming year as we continue to launch new products and services and broaden our research initiatives."
Joining the 23andMe Community
To learn more and embark on your own personal genetics journey, please visit: http://www.23andme.com.
23andMe is now available to consumers in the following locations: Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, the United Kingdom, the United States and Vatican City State.
23andMe, Inc. is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service™ enables individuals to gain deeper insights into their ancestry and inherited traits. 23andMe, Inc., was founded by Linda Avey and Anne Wojcicki in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. Its Series A investors include Genentech, Inc., Google Inc. (NASDAQ: GOOG) and New Enterprise Associates. More information is available at http://www.23andMe.com.